Riva Alessandro
SEC insider (Form 3/4/5 filer). CIK 0001867172. Director at BeOne Medicines Ltd. (ONC) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in PHILADELPHIA, PA.
Companies Riva Alessandro has filed insider reports for
- BeOne Medicines Ltd. (ONC): Director
- Century Therapeutics, Inc. (IPSC): Director
- BICYCLE THERAPEUTICS PLC (BCYC): Director
Riva Alessandro
CIK: 0001867172
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 11, 2026ONC
BeOne Medicines Ltd.
AwardDirect19K shares- - Jun 11, 2026IPSC
Century Therapeutics, Inc.
AwardDirectStock Option (right to buy)
74K shares- - May 22, 2026ONC
BeOne Medicines Ltd.
SaleDirect212 shares at avg. $309.51$66K - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
AwardDirect7.4K shares- - Jun 12, 2025IPSC
Century Therapeutics, Inc.
AwardDirectStock Option (right to buy)
44K shares- - May 21, 2025BGNE
BeiGene, Ltd.
AwardDirect11K shares- - Mar 25, 2025BCYC
BICYCLE THERAPEUTICS PLC
AwardDirect12.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  ONC BeOne Medicines Ltd. | Award | 18,980 | - | $0 | Direct |
| Jun 11, 2026 |  IPSC Century Therapeutics, Inc. | Award Stock Option (right to buy) | 74,000 | - | - | Direct |
| May 22, 2026 | ONC BeOne Medicines Ltd. | Sale | 212 | $309.51 | $65,617 | Direct |
| Jan 2, 2026 |  BCYC BICYCLE THERAPEUTICS PLC | Award | 7,380 | - | $0 | Direct |
| Jun 12, 2025 | IPSC Century Therapeutics, Inc. | Award Stock Option (right to buy) | 44,000 | - | - | Direct |
| May 21, 2025 |  BGNE BeiGene, Ltd. | Award | 10,985 | - | - | Direct |
| Mar 25, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Award | 12,500 | - | - | Direct |
1-7 of 7 transactions